Archives posted in: Pricing
Quest Diagnostics, a U.S. healthcare diagnostic company, had a positive FY 2024. Revenue rose 6.7% to $9.87 billion, and earnings before interest…
MoreEdwards Lifesciences, a global leader in structural heart innovation, reported a positive FY 2024. Revenue rose 8.6% to $5.4 billion and earnings…
MoreLabCorp, a laboratory services company for medical providers, pharmaceuticals, and researchers, had a positive FY 2024. Revenue rose 7% to $13.0 billion,…
MoreModerna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…
MoreTariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…
MoreBristol-Myers Squibb, a global biopharmaceutical company, had a mixed FY 2024. Revenue rose 7.3% to $48.3 billion while operating earnings fell 199%…
MoreRegeneron, a biotechnology company, had a mixed FY 2024. Revenue rose 8.3% to $14.2 billion, while operating profit fell 3.6% to $4.0…
MoreBaxter, a global healthcare product company, had a mixed FY 2024. Revenue rose 2.7% to $10.6 billion, while operating income fell 98%…
MoreChallenge Our pricing is challenged by discipline and predictability in capturing our fair share of the value we deliver to customers. Recommendation…
MoreHow large should a company’s pricing team be? How should executives and consultants even benchmark the size of a pricing team across…
More